Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q38610306)
Watch
English
Immunotherapy and tumor microenvironment
scientific article published on 15 October 2015
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
title
Immunotherapy and tumor microenvironment
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
main subject
immunotherapy
1 reference
based on heuristic
inferred from title
author
Haidong Tang
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
Yang-Xin Fu
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
author name string
Jian Qiao
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
language of work or name
English
0 references
publication date
19 October 2015
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
published in
Cancer Letters
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
volume
370
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
issue
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
page(s)
85-90
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
cites work
Engineering CAR-T cells: Design concepts
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Innate immune recognition of cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Immune checkpoint combinations from mouse to man.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Microenvironmental regulation of therapeutic response in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Immunotherapy and the belly of the beast
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculature.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Chemokines and chemokine receptors: positioning cells for host defense and immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Cytokines in cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
License for destruction: tumor-specific cytokine targeting.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Cancer drug resistance: an evolving paradigm
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Newly described pattern recognition receptors team up against intracellular pathogens
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Nivolumab plus ipilimumab in advanced melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Agonistic CD40 antibodies and cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
The blockade of immune checkpoints in cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
CpG still rocks! Update on an accidental drug
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Immunoregulation by tumor necrosis factor superfamily member LIGHT
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
CpG oligodeoxynucleotides as immunotherapy in cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Orchestrating the orchestrators: chemokines in control of T cell traffic
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
PD-1 and its ligands in tolerance and immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Prospect of targeting the CD40 pathway for cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Immunostimulatory monoclonal antibodies for cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Tumor-infiltrating T lymphocytes: friends or foes?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
IRF-7 is the master regulator of type-I interferon-dependent immune responses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Network communications: lymphotoxins, LIGHT, and TNF.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Cytokines in cancer immunity and immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Cytokines in cancer pathogenesis and cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Chemokines: agents for the immunotherapy of cancer?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Immunity against solid tumors?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Progress in human tumour immunology and immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Functions of cell surface heparan sulfate proteoglycans
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Chemokines and cell migration in secondary lymphoid organs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Development and maturation of secondary lymphoid tissues.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
A new era for cancer immunotherapy based on the genes that encode cancer antigens
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Mig and IP-10: CXC chemokines that target lymphocytes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Human tumor antigens recognized by T lymphocytes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Molecular and biological characterization of a murine ligand for CD40
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
6 September 2017
Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
14 September 2017
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
14 September 2017
Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
23 June 2018
Breakthrough of the year 2013. Cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
31 August 2018
Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
31 August 2018
From the analyst's couch: TLR-targeted therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
31 August 2018
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
31 August 2018
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
31 August 2018
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
31 August 2018
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
1 October 2018
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725050
retrieved
3 December 2018
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26477683
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26477683
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Priming of naive T cells inside tumors leads to eradication of established tumors
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26477683
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Chemokines in cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26477683
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26477683
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1016/J.CANLET.2015.10.009
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
PMC publication ID
4725050
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
PubMed publication ID
26477683
1 reference
stated in
Europe PubMed Central
PMC publication ID
4725050
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477683%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
ResearchGate publication ID
283012347
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
